COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=49799

Chaoqian Li

2534776680@qq.com

2020-02-19

Recruiting

RCT

Randomized

Parallel

Blind label

single-center

Treatment

Patients aged >=18 years with novel coronavirus pneumonia who agreed to participate in this trial and signed the informed consent.

1. Pregnant women, 2. Patients with a history of angina pectoris, myocardial infarction and other serious cardiovascular diseases, 3. The researchers judged that this study was not in the interests of patients.

2

Guangxi medical uniwresity

18

80

China

Moderate disease at enrollment

3: Moderate disease at enrollment

60

viral negative-transforming time;30-day cause-specific mortality;30-day cause-adverse events;30-day all-cause mortality;co-infections;Time from severe and critical patients to clinical improvement;Others (liver function; kidney function; myocardial enzyme);

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 4

[{"arm_notes": "", "treatment_id": 842, "treatment_name": "Mycobacterium", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]